Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Svante Pääbo, Mark McDonough, Judd Jessup

Premium

Svante Pääbo has been chosen as winner of the 2013 Genetics Prize of the Gruber Foundation, an accolade that includes a $500,000 award. Pääbo, who is director of the Department of Genetics at the Max Planck Institute for Evolutionary Anthropology, won the award because of his pioneering efforts in the field of molecular paleontology, which uses genomics technologies and approaches to study prehistoric life.


CombiMatrix announced that Chief Commercial Officer Mark McDonough will take over as CEO effective March 15. He succeeds Judd Jessup, who is retiring. McDonough joined CombiMatrix in August 2012 from Pathwork Diagnostics, where he was VP of sales, customer service, and training. He also has worked for US Labs, Dianon, Laboratory Corporation of America, EMC, and Ventana Medical Systems.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.